| |
No |
GPh (+) (n=10) |
GPh (-) (n=52) |
Univariate Analysis P |
Multivariate Analysis |
| Odds ratio (95% CI) |
P |
| Gender |
|
|
|
0.383 |
|
|
| Male |
47 |
6 |
41 |
|
|
|
| Female |
15 |
4 |
11 |
|
|
|
| Age |
|
|
|
0.815 |
|
|
| < 65 |
30 |
4 |
26 |
|
|
|
| > 65 |
32 |
6 |
26 |
|
|
|
| Hypertension |
|
|
|
0.028 |
|
0.980 |
| Absent |
35 |
2 |
33 |
|
1 |
|
| Present |
27 |
8 |
19 |
|
1.031(0.87,12.239) |
|
| Diabetes mellitus |
|
|
|
0.8416 |
|
|
| Absent |
48 |
7 |
41 |
|
|
|
| Present |
14 |
3 |
11 |
|
|
|
| Serum albumin |
|
|
|
0.494 |
|
|
| < 4.3 g/dl |
28 |
6 |
22 |
|
|
|
| > 4.3 g/dl |
34 |
4 |
30 |
|
|
|
| ICG R15 |
|
|
|
0.480 |
|
|
| < 12 % |
28 |
3 |
25 |
|
|
|
| >12 % |
34 |
7 |
27 |
|
|
|
| Remnant K value |
|
|
|
0.647 |
|
|
| < 0.05 /min |
32 |
4 |
28 |
|
|
|
| > 0.05 /min |
30 |
6 |
24 |
|
|
|
| HBV infection |
|
|
|
>0.999 |
|
|
| Absent |
56 |
9 |
47 |
|
|
|
| Present |
6 |
1 |
5 |
|
|
|
| HCV infection |
|
|
|
0.458 |
|
|
| Absent |
47 |
9 |
38 |
|
|
|
| Present |
15 |
1 |
14 |
|
|
|
| History of chemotherapy |
|
|
|
>0.999 |
|
|
| Absent |
28 |
5 |
23 |
|
|
|
| Present |
34 |
5 |
29 |
|
|
|
| Arterial sclerosis (proximal and/or distal area) |
|
|
|
0.031 |
|
0.021 |
| Absent |
57 |
7 |
50 |
|
1 |
|
| Present |
5 |
3 |
2 |
|
24.000(1.615, 356.729) |
|
| Embolic agents (proximal area) |
|
|
|
<0.001 |
|
<0.001 |
| Absent |
57 |
6 |
51 |
|
1 |
|
| Present |
5 |
4 |
1 |
|
64.000(3.248, 1261.015) |
|
| Embolic agents (distal area) |
|
|
|
0.196 |
|
|
| Absent |
27 |
2 |
25 |
|
|
|
| Present |
35 |
8 |
27 |
|
|
|
| CI: confidence interval; PVE: portal vein embolization; Proximal area, area within 3cm from the tumor margin; Distal area, area over 3cm from the tumor margin; ICG R15, 15-min indocyanine green retention rate; ICG K, indocyanine green plasma clearance rate;Remnant K, estimated ICG-K value for the future remnant liver |
|
